Hot topics in allergen immunotherapy, 2023: Current status and future perspective

Area of Science:

• Immunology
• Allergy Research
• Clinical Medicine

Background:

• Allergen immunotherapy (AIT) offers clinical and quality-of-life benefits, alongside long-term cost-effectiveness.
• Established mechanisms include shifts in T- and B-cell responses, antibody changes (IgG1, IgG4), and reduced inflammatory cell infiltration.

Purpose of the Study:

• To review recent advances and future prospects in allergen immunotherapy.
• To highlight the role of novel strategies, biomarkers, and technologies in personalizing AIT.
• To discuss evolving clinical trial methodologies and cost-effectiveness.

Main Methods:

• Comprehensive literature review of recent developments in AIT.
• Analysis of emerging biomarkers, molecular diagnostics, and digital health applications.
• Evaluation of novel AIT formulations, clinical trial designs, and real-world evidence.

Main Results:

• Personalized AIT approaches are enhanced by biomarkers, molecular diagnostics, and mobile health.
• Artificial intelligence aids in managing complex data, predicting subtypes, and monitoring responses.
• Novel AIT preparations and adaptive clinical trial designs show promise for increased flexibility and reduced costs.
• AIT demonstrates clear long-term cost-effectiveness compared to pharmacotherapy.

Conclusions:

• Allergen immunotherapy is a dynamic field with significant growth potential.
• Ongoing research is crucial for defining endpoints, biomarkers, and understanding mechanisms like the placebo effect.
• Future directions involve innovative treatments and refined clinical evaluation methods.